[1]王宇.间质植入近距离照射治疗前列腺癌[J].国际放射医学核医学杂志,2001,25(5):233-236.
　WANG Yu.Interstitial implantation brachytherapy for the treatment of prostate carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(5):233-236.
点击复制

间质植入近距离照射治疗前列腺癌(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
25
期数:
2001年第5期
页码:
233-236
栏目:
综述
出版日期:
1900-01-01

文章信息/Info

Title:
Interstitial implantation brachytherapy for the treatment of prostate carcinoma
作者:
王宇
210009 江苏 南京, 南京东南大学医学院核医学技术研究所
Author(s):
WANG Yu
Nuclear Medicine technical institute, Medical College of South East University, Jiangsu Nanjing 210009, China
关键词:
前列腺癌; 近距离照射治疗; 放射性核素籽源
Keywords:
prostate carcinoma; brachytherapy; radioisotope seeds
分类号:
R817.5
摘要:
简述间质植入近距离照射治疗前列腺癌的概况及操作方法,介绍所用核素的特点和选择,评价该疗法的适应证、临床疗效、并发症及与其他疗法的比较。
Abstract:
It briefly describes the current states and operative procedure of interstitial implantation brachytherapy treatment of prostate carcinoma. The characteristics and selection of employed radioisotopes are introduced.It also evaluates the indications,results and complications of this technique,and compar with the other therapies.

参考文献/References:

[1] Stone N N, Ramin SA, Wesson MF, et al. Laparoscopic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed prostate[J]. J Urol, 1995, 153:1555-1560.
[2] Blasko JC, Grimm PD, Ashley R, et al. Palladium-103 brachytherapy for prostate carcinoma[J]. Int J Radiat Oncol Biol Phys, 2000, 46(4):839-850.
[3] Sylvester J, Blasko JC, Grimm P, et al. Interstitial implantation techniques in prostate cancer[J]. J Surg Oncol, 1997, 66:65-75.
[4] Ling CC. Permanent implants using Au-198, Pd-103 and I-125:Radiobioligical considerations based on the linear quadratic model[J]. Int J Radiat Oncol Biol Phys, 1992, 23:81-87.
[5] Cha CM, Potters L, Ashley R, et al. Isotope selection for patients undergoing prostate brachytherapy[J]. Int J Radiat Oncol Biol Phys, 1999, 45(2):391-395.
[6] Wuu CS, Ennis RD, Schiff PB, et al. Dosimetric and volumetric criteria for selecting a source activity and a source type (125I or 103Pd) in the presence of irregular seed placement in permanent prostate implans[J]. Int J Radiat Oncol Biol Phys, 2000, 47(3):815-820.
[7] Blasko JC, Grimm PD, Ragde H, et al. Brachytherapy and organ preservation in the management of carcinoma of the prostate[J]. Semin Radiat Oncol, 1993, 3:240-249.
[8] Wallner K, Roy J, Harrion L, et al. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 brachytherapy[J]. Int J Radiat Oncol Biol Phys, 1995, 32:465-471.
[9] Anderson LL. Spacing nomograph for interstitial implants of I-125 seeds[J]. Med Phys, 1976, 3:48-51.
[10] Anderson LL, Moni JV, Harrion LB, et al. A nomograph for permanent implants of palladium-103 seeds[J]. Int J Radiat Oncol Biol Phys, 1993, 27:129-135.
[11] Yu Y, Waterman FM, Suntharalingam N, et al. Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants[J]. Int J Radiat Oncol Biol Phys, 1996, 34:717-725.
[12] Anon. Consensus statement:guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel[J].Int J Radat Oncol Biol Phys, 1997, 37(5):1035-1041.
[13] Prestidge BR, Hoak DC, Grimm PD, et al. Post-treatment biopsy results following interstitial brachytherapy in early stage prostate cancer[J]. Int J Radiat Oncol Biol Phys, 1997, 37:31-39.
[14] Ragde H, Korb LJ, Elgamal AA, et al. Modern Prostate Brachytherapy:prostate bpecific antigen results in 219 patients with up to 12 years of observed follow-up[J].Cancer, 2000, 89(1):135-141.
[15] Blasko JC. Brachytherapy[J]. Urology, 2000, 55:306-308.
[16] Brachman DG, Thomas T, Hilbe J, et al. Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients:results from a single practice[J]. Int J Radiat Oncol Biol Phys, 2000, 48(1):111-117.
[17] D’Amico AV, Whittington R, Malkowicz SB, et al.Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer[J]. JAMA, 1998, 280(11):969-974.
[18] Nori D, Mori J. Current issues in techniques of prostate brachytherapy[J]. Semin Surg Oncol, 1997, 13:444-453.
[19] Arterbery VE, Frazier A, Dalmia P, et al. Quality of life after permanent prostate implant[J]. Semin Surg Oncol, 1997, 13:461-464.
[20] Baird MC, Holt RW, Selby TL, et al. Improvement of transperineal implant dosimetry by intraoperative cystoscopic confirmation of prostate anatomy[J]. J Urol, 2000, 164:406-416.
[21] Whittington R, Broderick GA, Arger P, et al. The effect of androgen deprivation on the early changes in prostate volume following transperineal ultrasound guide interstitial therapy for localized carcinoma of the prostate[J]. Int J Radiat Oncol Biol Phys, 1999, 44(5):1107-1110.

相似文献/References:

[1]郝玉美,贺欣,宋娜玲.前列腺癌干细胞分离方法研究进展[J].国际放射医学核医学杂志,2013,37(5):296.[doi:10.3760/cma.j.issn.1673-4114.2013.05.011]
　HAO Yu-mei,HE Xin,SONG Na-ling.Advanced research on separating prostate cancer stem cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):296.[doi:10.3760/cma.j.issn.1673-4114.2013.05.011]
[2]秦岚.前列腺癌近距离放射治疗的进展[J].国际放射医学核医学杂志,2005,29(4):159.
　QIN Lan.Evolution of brachytherapy for prostate carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):159.
[3]廖安燕,王俊杰.持续低剂量率照射治疗前列腺癌的生物学效应[J].国际放射医学核医学杂志,2005,29(4):190.
　LIAO An-yan,WANG Jun-jie.The biological effect of continuous low-dose rate irradiation for prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):190.
[4]王俊杰.放射性粒子近距离治疗前列腺癌:临床篇[J].国际放射医学核医学杂志,2002,26(3):101.
　WANG Jun-jie.Radioactive seed implantation treatment for prostate carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(5):101.
[5]陈立波.钠/碘同向转运体与放射性碘治疗[J].国际放射医学核医学杂志,2001,25(6):258.
　CHEN Li-bo.The sodium/iodide symporter and radioiodide therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(5):258.
[6]许杨.前列腺特异性抗原及其临床应用[J].国际放射医学核医学杂志,2000,24(5):201.
　XU Yang.Prostate specific antigen and its clinical apptication[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(5):201.
[7]陆汉魁,林祥通,刘家慧,等.乳腺癌和前列腺癌的类固醇受体显像研究现状[J].国际放射医学核医学杂志,1996,20(3):106.

备注/Memo

备注/Memo:
收稿日期:2001/6/10。
基金项目:江苏省科技厅应用基础资助项目(BJ2000004)
作者简介:王宇(1973-),女,黑龙江齐齐哈尔人,南京东南大学医学院硕士研究生。
更新日期/Last Update: 1900-01-01